SHELDON STEPHEN (Chief Financial Officer) received a stock award from KUVATRIS THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 4/14/2023ACC: 0001104659-23-045778
Officer· Chief Financial Officer
Since Aug 2022
+100K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
100K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+100K
Price / share
—
Trade value
—
% of position
66.7%
4/13/2023
150K→250K
Total
Net shares
+100K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/13/2023 | A · Award | +100K | — | — | 66.7% | 150K | 250K |
| Total | +100K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned18.80K
Total
18.80K indirect18.80K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 18.80K | Indirect |
| Total | 18.80K | 18.80K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported